If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: BW BUSINESSWORLD
Hatchtech: Dr Reddy's Ordered To Pay USD 46.25 Mn To Hatchtech
Dr Reddy's had announced the receipt of an approval of XEGLYZE under the NDA (new drug application) category from the US Food and Drug Administration (USFDA).
Read full article »
Hatchtech's Competitors
|
Hatchtech's News
|
Hatchtech's Financials
Follow
Followers on Owler
2
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO
Hugh Alsop
CEO Approval Rating
68/100
Weigh In
Hatchtech develops head lice treatment products.
Read more
See Hatchtech company profile »
